Saving your money for next purchases
Keverprazan Hydrochloride Tablets
Keplasma Hydrochloride Tablets (trade name: Bewin [3]) is a potassium ion competitive acid blocker (P-CAB) [6-7] jointly developed by Fosun Pharma and Kefopex Pharmaceuticals and exclusively commercialized by Fosun Pharma. It is suitable for the treatment of duodenal ulcers and reflux esophagitis.
On February 15, 2023 [2], the National Medical Products Administration approved Keplasma Hydrochloride Tablets for marketing. [1]
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
